This program examines state-of-the-art strategies for assessment of early lung disease in patients with CF. It reviews the importance of early intervention and optimal strategies to prevent airway obstruction in patients with CF
Leading experts address the current evidence-based best practices, with educational and inspirational sessions on adherence, originally presented at the 29th North American Cystic Fibrosis Conference.
Hear from Francis Collins, Tsui Lap-Chee, and Jack Riordan whose labs worked together to discover the CF gene. CF luminaries Bob Beall, Pamela Davis, Philip M. Farrell and others share how the discovery of the CF gene changed everything. Faculty present the clinical data and how patient care is evolving.
Meet Daniel, a three-year-old whose routine throat culture just grew P. aeruginosa, originally presented at the 28th North American Cystic Fibrosis Conference.
Originally presented at the 2013 North American Cystic Fibrosis Conference, this program covers differentiation of CF classes and current/potential therapies and using the CFTR2 database.
Learn about the 5 classes of CFTR mutations, the latest research on emerging therapies for each mutation class and follow four individuals with CF. These case-based modules were presented at the 36th European Cystic Fibrosis Society Conference in Lisbon, Portugal.
This program examines state-of-the-art strategies for assessment of early lung disease in patients with CF. It reviews the importance of early intervention and optimal strategies to prevent airway obstruction in patients with CF
eCystic Fibrosis Review: Featured Cases: Emerging Pathogens in Cystic Fibrosis
eCystic Fibrosis Review: Strategies for the Improvement of Nutrition Outcomes
eCystic Fibrosis Review: Featured Cases: Exacerbation Therapies
eCystic Fibrosis Review:Featured Cases: Allergic Bronchopulmonary Aspergillosis (ABPA)
This program describes the correlation between a patient’s CFTR genotype and their CF phenotype, explains the importance of genetic testing in suspected adult-onset CF, and identifies the practical uses of the CFTR2 database.
Presented at NACFC Anaheim 2011 this symposium presentation offers information on the current treatment options for patients with cystic fibrosis. Mike Boyle, MD, from Johns Hopkins University School of Medicine offers a 25-minute look at the basics of CF, then describes genotype and CF phenotype relationships. The presentation includes a review the influences of severity of lung disease and outcomes in CF, followed up by issues related to adherence.
Presented at NACFC Anaheim 2011 this symposium presentation offers information on the current treatment options for patients with cystic fibrosis. Mike Boyle, MD, from Johns Hopkins University School of Medicine offers a 25-minute look at the basics of CF, then describes genotype and CF phenotype relationships. The presentation includes a review the influences of severity of lung disease and outcomes in CF, followed up by issues related to adherence.
Presented at NACFC Anaheim 2011 this symposium presentation offers information on the current treatment options for patients with cystic fibrosis. Mike Boyle, MD, from Johns Hopkins University School of Medicine offers a 25-minute look at the basics of CF, then describes genotype and CF phenotype relationships. The presentation includes a review the influences of severity of lung disease and outcomes in CF, followed up by issues related to adherence.
eCystic Fibrosis Review: Adherence to Chronic Inhaled Therapies
eCystic Fibrosis Review: Featured Cases: The Role of Exercise and Physical Activity in Optimizing Outcomes Among Patients with CF
eCystic Fibrosis Review: Featured Cases: Interventions to Improve Nutrition in Patients with CF
eCystic Fibrosis Review: Featured Cases: Modifiers of CF Lung Disease
eCystic Fibrosis Review: Featured Cases: New Inhalation Therapies
Featured Cases: State-of-the-Art Treatment for CF Lung Disease
eCystic Fibrosis Review: Featured Cases: Vitamin D and Bone Health
eCystic Fibrosis Review:Featured Cases: Nutritional Challenges and Complications in Patients with CF
eCystic Fibrosis Review:Featured Cases: Cystic Fibrosis–Related Diabetes
eCystic Fibrosis Review:Measurement of Early Lung Disease in Children With Cystic Fibrosis
eCystic Fibrosis Review:Emerging Pathogens in Cystic Fibrosis
eCystic Fibrosis Review: How to Interpret Genetic Tests for Cystic Fibrosis